戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ability to belch, gas bloating and increased flatulence.
2 e microflora and their propensity to produce flatulence.
3 isk (RR) 0.59; 95% CI: 0.36-0.97; P = 0.04], flatulence (14% vs 25%; RR: 0.57; 95% CI: 0.35-0.91; P =
4 ng (7.1% vs. 21.4%; P = 0.242) and increased flatulence (7.1% vs. 42.9%; P = 0.018) was lower compare
5                            Symptoms included flatulence (86%), abdominal distention or being underwei
6               Of 188 reported AEs, diarrhea, flatulence, abdominal pain/cramping, and constipation we
7 en and intolerance symptoms (abdominal pain, flatulence, and diarrhea) were carefully monitored for 8
8 accharides (RFOs) are mainly responsible for flatulence by taking soybean derived food products.
9 ped to better understand the behavior of the flatulence-causing oligosaccharides in cowpea seeds duri
10 ewly emerging parasite that causes diarrhea, flatulence, fatigue, and abdominal pain leading to weigh
11                    The clinical evolution of flatulence followed similar patterns in the three groups
12      At 5 years, the Dakkak dysphagia score, flatulence, inability to belch, and inability to relieve
13     Patients had more feelings of repletion, flatulence, intestinal murmurs, and burping (p < 0.04).
14                                         Mild flatulence is frequently observed by subjects being fed
15 ised, IBS symptom scores, pain, bloating and flatulence levels, stool frequency, stool consistency, e
16 oose stools (p < 0.01), bloating (p < 0.05), flatulence (p < 0.01), urgency (p < 0.05) and any sympto
17 ificant within-group reductions in days with flatulence (p < 0.035), incomplete evacuation (p < 0.05)
18  = 0.03) and the proportion of patients with flatulence (p = 0.02).
19               S-LNP subjects have underlying flatulence that is misattributed to lactose intolerance.
20 strointestinal symptoms, including diarrhea, flatulence, weight loss, abdominal discomfort, and nause
21                           Abdominal pain and flatulence were the most common adverse events.
22 s type, nausea, vomiting, abdominal pain and flatulence) were assessed by a self-administered ad-hoc
23 g from the stomach and less gas bloating and flatulence, whereas reflux is reduced to a similar exten

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。